Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Status:
Terminated
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Rosuvastatin may stop the growth of tumor cells by blocking some of the enzymes
needed for cell growth. Giving rosuvastatin after surgery may kill any tumor cells that
remain after surgery. It may also keep polyps from forming or colon cancer from coming back.
It is not yet known whether rosuvastatin is more effective than a placebo in treating colon
cancer that was removed by surgery.
PURPOSE: This randomized phase III trial is studying rosuvastatin to see how well it works
compared with placebo in treating patients with stage I or stage II colon cancer that was
removed by surgery.